"10.1371_journal.pone.0124402","plos one","2015-04-29T00:00:00Z","Genane Loheswaran; Sophie Soklaridis; Peter Selby; Bernard Le Foll","Translational Addiction Research Laboratory, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Ontario, Canada; Department of Pharmacology, University of Toronto, Toronto, Ontario, Canada; CAMH Education, Centre for Addiction and Mental Health, Toronto, Ontario, Canada; Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada; Department of Family and Community Medicine, University of Toronto, Toronto, Ontario, Canada; Ambulatory Care and Structured Treatments, Centre for Addiction and Mental Health, Toronto, Ontario, Canada; Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada","Conceived and designed the experiments: GL PS BLF. Performed the experiments: GL. Analyzed the data: GL. Contributed reagents/materials/analysis tools: PS BLF. Wrote the paper: GL PS BLF SS.","The authors would like to report the following possible conflicts of interest. Dr. Bernard Le Foll has received speaker fees from Mylan Pharmaceuticals and GRAND awards from Pfizer. Dr. Peter Selby has received consulting fees from Pfizer Inc./Canada, Pfizer Global, NABI Pharmaceuticals, V-CC Systems Inc. (eHealth Behaviour Change Software Co.) and speaker bureau/honoraria from Pfizer Inc. Canada and Pfizer Global. Dr. Sophie Soklaridis and Ms. Genane Loheswaran do not have any potential conflicts of interest to report. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.","2015","04","Genane Loheswaran","GL",4,TRUE,3,1,1,4,TRUE,TRUE,FALSE,0,NA,FALSE
